Opendata, web and dolomites

IBEX QDR SIGNED

IBEX QDR: A Ground-breaking Technological Upgrade based on Quantitative Digital Radiography to Exploit the Full Diagnostic Potential of Standard Digital X-Ray

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 IBEX QDR project word cloud

Explore the words cloud of the IBEX QDR project. It provides you a very rough idea of what is the project "IBEX QDR" about.

   innovations    benefits    turn    invested    simplified    outlined    diagnosis    cancer    conceived    scarce    unleash    altogether    alleviated    detection    bn    tests    symptoms    osteoporosis    million    dexa    finalising    clinical    disability    lack    health    productivity    diagnostic    treatment    bmd    profits    market    readiness    representing    entails    professionals    first    population    routine    qdr    density    upgrade    once    completing    ibex    patented    dose    37    natural    expensive    examination    enhances    flows    digital    optimisations    diseases    quality    quantitative    ray    roi    radiology    occurs    image    age    risk    lower    radiography    fracture    business    technological    scans    fold    bone    radiation    burden    warning    safer    securing    confirmed    social    manufacturers    screening    obtain    validation    besides    standard    ageing    healthcare    limiting    efficient    grouped    individuals    severe    images    mineral    public    reducing    detector    providers    people    16    engagement   

Project "IBEX QDR" data sheet

The following table provides information about the project.

Coordinator
IBEX INNOVATIONS LTD 

Organization address
address: DISCOVERY 2 NETPARK
city: SEDGEFIELD
postcode: TS21 3FH
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://ibexinnovations.co.uk
 Total cost 1˙611˙542 €
 EC max contribution 1˙611˙542 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IBEX INNOVATIONS LTD UK (SEDGEFIELD) coordinator 1˙611˙542.00

Map

 Project objective

Bone density loss is a natural process that affects us all as we age. As the loss advances, so does the risk of fracture. The lack of warning symptoms or routine tests results in a late detection of severe density loss (osteoporosis), often when the first fracture occurs. Besides being a major social burden, in the EU it entails costs of €37 bn/year in treatment, disability or productivity loss, which could be alleviated if population-wide bone health screening methods were available. Today, measurement of bone mineral density (BMD) is only available through scarce and expensive DEXA scans, limiting testing to referred individuals grouped as high risk of osteoporosis. In response, we at IBEX Innovations have developed and patented IBEX-Quantitative Digital Radiography (IBEX-QDR). Conceived as a cost-efficient upgrade for standard digital radiography systems, it enhances the quality of digital X-ray images and enables these systems to measure BMD. All while reducing by 2-fold the X-ray dose needed to obtain the image. Altogether, IBEX QDR will unleash the diagnostic potential of digital radiology, enabling routine screening of bone density with any standard X-ray examination. In a Phase 1 project we confirmed the market opportunities for IBEX-QDR, outlined technical optimisations and achieved high-level engagement with X-ray detector and system manufacturers and healthcare providers. Now in Phase 2 we aim to reach market readiness by finalising the technological development, completing its clinical validation and securing the business aspects of the project. Once in the market, IBEX QDR will bring significant benefits for healthcare systems (early diagnosis and lower impact of ageing diseases), professionals (safer and simplified work-flows) and public health (lower radiation dose and less X-ray induced cancer). In turn, in 5 years it will provide us €16.7 million profits, 16 new people and a ROI of €9.37 per euro invested, representing c.1% of the target market.

 Deliverables

List of deliverables.
Updated Marketing materials (Brochures, website) Websites, patent fillings, videos etc. 2020-04-25 01:45:01
Software Sign-off and Release Other 2020-04-25 01:45:11

Take a look to the deliverables list in detail:  detailed list of IBEX QDR deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IBEX QDR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IBEX QDR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

FAIR (2020)

FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA

Read More